Tumor microenvironment and immunotherapy of oral cancer

Eur J Med Res. 2022 Oct 8;27(1):198. doi: 10.1186/s40001-022-00835-4.

Abstract

Oral cancer is one of the most common malignant tumors of the head and neck, not only affects the appearance, but also affects eating and even endangers life. The clinical treatments of oral cancer mainly include surgery, radiotherapy, and chemotherapy. However, unsatisfactory therapeutic effect and toxic side effects are still the main problems in clinical treatment. Tumor microenvironment (TME) is not only closely related to the occurrence, growth, and metastasis of tumor but also works in the diagnosis, prevention, and treatment of tumor and prognosis. Future studies should continue to investigate the relationship of TME and oral cancer therapy. This purpose of this review was to analyze the characteristics of oral cancer microenvironment, summarize the traditional oral cancer therapy and immunotherapy strategies, and finally prospect the development prospects of oral cancer immunotherapy. Immunotherapy targeting tumor microenvironment is expected to provide a new strategy for clinical treatment of oral cancer.

Keywords: Immune checkpoint blockade; Immune tolerance; Immunotherapy; Oral cancer; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Humans
  • Immunotherapy / methods
  • Mouth Neoplasms* / therapy
  • Tumor Microenvironment*